Ali Khan, MD
Hospitalist · Syracuse, NYNPI 1588985782
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 315 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,128, 8.7 times the $246 reported in 2021. Among hospitalist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 315 payments — averaging $19.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$742
- AbbVie$676
- GSK$623
- Novo Nordisk$568
- Viiv Healthcare Company$506
- Pfizer$404
- plus $2K from 28 others
What the payments were for
- Food & beverage$6,008100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 26 | $742 |
| AbbVie | 45 | $676 |
| GSK | 31 | $623 |
| Novo Nordisk | 37 | $568 |
| Viiv Healthcare Company | 29 | $506 |
| Pfizer | 29 | $404 |
| AstraZeneca | 12 | $360 |
| Johnson & Johnson(2 entities) | 15 | $318 |
| Madrigal Pharmaceuticals | 7 | $287 |
| Astellas Pharma US Inc | 6 | $146 |
| Lilly USA, LLC | 8 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $121 |
| Ferring Pharmaceuticals Inc. | 5 | $104 |
| Sanofi-aventis U.S. LLC | 4 | $99 |
| Bayer | 5 | $86 |
| Merck | 5 | $86 |
| Amgen | 5 | $80 |
| Shionogi Inc | 4 | $76 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $70 |
| Exact Sciences | 4 | $66 |
| CSL Behring | 2 | $54 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $54 |
| Collegium Pharmaceutical, Inc. | 3 | $45 |
| Boehringer Ingelheim | 3 | $45 |
| Indivior Inc. | 2 | $42 |
| Paratek Pharmaceuticals, Inc. | 2 | $37 |
| Abbott | 2 | $35 |
| W. L. Gore & Associates, Inc. | 1 | $29 |
| Shield Therapeutics Inc | 2 | $28 |
| Insulet Corporation | 1 | $25 |
| Amarin Pharma, Inc. | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Phadia US Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,008 in reported general payments places this provider in the 95th percentile of 1,860 hospitalist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 53 | $56,435 |
| XareltoRivaroxaban | 31 | $43,545 |
| OzempicSemaglutide | 29 | $41,851 |
| TrulicityDulaglutide | 32 | $38,110 |
| JanuviaSitagliptin Phosphate | 19 | $26,856 |
| JardianceEmpagliflozin | 23 | $22,043 |
| FarxigaDapagliflozin Propanediol | 18 | $21,575 |
| CaplytaLumateperone Tosylate | 11 | $18,856 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $18,761 |
| VraylarCariprazine Hcl | 12 | $16,334 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $13,014 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 13 | $6,988 |
| VascepaIcosapent Ethyl | 14 | $4,974 |
| Levothyroxine Sodium | 175 | $4,460 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 19 | $4,164 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $404 | $56,43553 claims |
| Johnson & JohnsonXarelto | $318 | $43,54531 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Shingrix | $623 | $42,92774 claims |
| Novo NordiskOzempic | $568 | $41,85129 claims |
| Lilly USA, LLCTrulicity | $131 | $38,11032 claims |
| MerckJanuvia | $86 | $26,85619 claims |
| Boehringer IngelheimJardiance | $45 | $22,04323 claims |
| AstraZenecaFarxiga | $360 | $21,57518 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $54 | $18,85611 claims |
| AbbVieVraylar, Synthroid | $676 | $17,30733 claims |
| Sanofi-aventis U.S. LLCLantus | $99 | $72212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,860 hospitalist providers in New York.
Other hospitalist in Syracuse
- Gagan Jot SinghSyracuse$6K
- Hammad RahmanSyracuse$5K
- Mostafa VasighSyracuse$5K
- Manika SuryadevaraSyracuse$4K
- Nelson Chan-HungRochester$445K
- Saquib RahimFlushing$239K
- Zainab Mogul-AshrafMiddletown$190K
- Salman AzimRochester$88K
- Usman SiddiquiNyack$70K
- Yair SapersteinNew York$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.